Compare Stocks › HCA vs MS

HCA Healthcare, Inc. (HCA) vs Morgan Stanley (MS): Which Is the Better Buy in 2026?

As of 2026-11-01, HCA is overvalued at $473, with a DCF intrinsic value of $297 and a margin of safety of -59%. MS is undervalued at $184, with an intrinsic value of $314 and a margin of safety of 41%. Of the two, MS has the wider margin of safety.

HCA
HCA Healthcare, Inc.
$473.19
VS
MS
Morgan Stanley
$184.30

Rewards

HCA
  • ★HCA Healthcare, Inc. has maintained ROIC above 15% for 4 consecutive years, indicating a durable competitive advantage.
  • ★HCA Healthcare, Inc. scores 95/100 on the Economic Moat Score (Wide Moat), with roic consistency as the strongest competitive dimension.
  • ★Free cash flow has grown at a 23.1% CAGR over the past 4 years, demonstrating strong earnings power growth.
MS
  • ★Gross margin of 87.3% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Morgan Stanley scores 80/100 on the Economic Moat Score (Wide Moat), with revenue predictability as the strongest competitive dimension.
  • ★Each dollar of retained earnings has created $3.56 of earning power — management is an exceptional capital allocator.

Risks

HCA
  • ⚠FCF yield of 7.8% suggests reasonable valuation assuming continued moderate growth.
MS
  • ⚠Altman Z-Score of 0.29 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
  • ⚠13 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.

Key Valuation Metrics

Learn more →
HCA
MS
Valuation
$7.69B
Free Cash Flow
N/A
7.78%
FCF Yield
N/A
15.69
Trailing P/E
14.62
15.16
Forward P/E
13.50
Quality & Moat
17.59%
ROIC
3.47%
N/A
ROE
13.84%
42.76%
Gross Margin
87.31%
1.43
PEG Ratio
1.61
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
3.26
Net Debt / EBITDA
N/A
0.66%
Dividend Yield
2.50%
HCA: 2Ties: 1MS: 4
HCAMS

Historical Fundamentals

Learn more →
HCA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

MS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
HCA
$2.43
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$15.76B
Δ Market Cap
+$38.30B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
MS
$6.65
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$20.84B
Δ Market Cap
+$138.59B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
HCA
59.3% Overvalued
Price is 59.3% above estimated fair value
Current Price: $473.19
Fair Value: $297.02
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
MS
41.3% Margin of Safety
Price is 41.3% below estimated fair value
Current Price: $184.30
Fair Value: $313.71
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
HCA

What growth rate is the market pricing in at $473?

+9.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +7.4%

The market implies +9.1% Owner Earnings growth, roughly in line with history — reasonably priced.

Standard FCF implies +7.4%, reflecting ongoing growth investment.

MS

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
HCA
95/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. ROIC Consistency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.
MS
80/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat driven primarily by revenue predictability. Margin Stability is the area most vulnerable to competitive pressure.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
HCA
-2.78
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
MS
-2.09
Possible Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
HCA
Insiders 17.2%Institutions 81.5%Retail & Other 1.3%
No. of Institutional Holders1,878
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
MS
Insiders 24.4%Institutions 63.5%Retail & Other 12.1%
No. of Institutional Holders3,458
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
HCA
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
MS
0
Buys (3M)
0
Buys (12M)
PETERSON DOUGLAS L
Director
$5,630
@ $156.39 · 2025-10-17
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
HCA
0
Sells (3M)
6
Sells (12M)
Total value (12M): $31.12M
MCALEVEY MICHAEL R.
Officer
$903,537
@ $533.37 · 2026-02-18
BERRES JENNIFER
Officer
$4.13M
@ $514.58 · 2026-02-11
WYATT CHRISTOPHER F
Officer
$2.02M
@ $505.00 · 2026-02-11
CUFFE MICHAEL S
Officer
$747,135
@ $498.09 · 2026-02-03
HAZEN SAMUEL N
Chief Executive Officer
$21.48M
@ $501.04 · 2026-02-03
MCALEVEY MICHAEL R.
Officer
$1.84M
@ $473.79 · 2025-11-05
CUFFE MICHAEL S
Officer
$1.61M
@ $418.84 · 2025-09-08
FOSTER JON MARK
Officer
$5.80M
@ $369.32 · 2025-05-13
BERRES JENNIFER
Officer
$3.08M
@ $322.59 · 2025-02-14
WHALEN KATHLEEN M
Officer
$527,677
@ $357.99 · 2024-11-14
AKDAMAR EROL R
Officer
$1.02M
@ $353.00 · 2024-11-14
BILLINGTON PHILLIP G
Officer
$1.36M
@ $350.00 · 2024-11-14
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
MS
0
Sells (3M)
13
Sells (12M)
Total value (12M): $48.28M
SCHAPIRO MARY L
Director
$212,055
@ $212.06 · 2026-07-28
PIZZI MICHAEL A
Officer
$5.21M
@ $215.55 · 2026-07-17
GROSSMAN ERIC F
Officer
$2.12M
@ $190.75 · 2026-04-20
SIMKOWITZ DANIEL A
President
$2.78M
@ $189.24 · 2026-04-17
CRAWLEY MANDELL L.
Officer
$3.04M
@ $188.22 · 2026-04-16
SAPERSTEIN ANDREW MICHAEL
President
$9.74M
@ $188.59 · 2026-04-16
SIMKOWITZ DANIEL A
President
$6.02M
@ $182.61 · 2026-01-30
YESHAYA SHARON
Chief Financial Officer
$2.94M
@ $185.77 · 2026-01-20
SMITH CHARLES AUBREY III
Officer
$1.55M
@ $182.08 · 2026-01-20
GROSSMAN ERIC F
Officer
$3.97M
@ $184.00 · 2026-01-20
CRAWLEY MANDELL L.
Officer
$1.44M
@ $183.45 · 2026-01-20
PIZZI MICHAEL A
Officer
$3.69M
@ $184.55 · 2026-01-20
SAPERSTEIN ANDREW MICHAEL
President
$5.57M
@ $183.62 · 2026-01-20
PICK EDWARD N.
Chief Executive Officer
$16.43M
@ $164.34 · 2025-10-31
SMITH CHARLES AUBREY III
Officer
$2.81M
@ $140.30 · 2025-07-17
GROSSMAN ERIC F
Officer
$1.69M
@ $141.12 · 2025-07-17
SIMKOWITZ DANIEL A
President
$4.09M
@ $141.13 · 2025-07-17
PIZZI MICHAEL A
Officer
$2.53M
@ $140.62 · 2025-07-17
SIMKOWITZ DANIEL A
President
$3.70M
@ $127.37 · 2025-05-12
HERZ ROBERT H
Director
$95,459
@ $119.32 · 2025-05-02
SAPERSTEIN ANDREW MICHAEL
President
$4.80M
@ $120.00 · 2025-05-02
GROSSMAN ERIC F
Officer
$1.12M
@ $111.65 · 2025-04-15
CRAWLEY MANDELL L.
Officer
$1.15M
@ $138.06 · 2025-01-22
GROSSMAN ERIC F
Officer
$1.78M
@ $136.20 · 2025-01-21
SIMKOWITZ DANIEL A
President
$5.00M
@ $136.61 · 2025-01-21
AKRAM RAJA
Chief Financial Officer
$2.38M
@ $136.01 · 2025-01-21
PIZZI MICHAEL A
Officer
$2.52M
@ $136.92 · 2025-01-21
SAPERSTEIN ANDREW MICHAEL
President
$4.20M
@ $136.43 · 2025-01-21
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
HCA
FearGreed
😐Neutral(55/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
MS
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
HCA
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (55)
MS
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View HCA Full AnalysisView MS Full Analysis

Frequently Asked Questions: HCA vs MS

Is HCA Healthcare, Inc. or Morgan Stanley more undervalued in 2026?▼

Based on our discounted cash flow model, MS trades at a 41.3% margin of safety (intrinsic value $314 vs. price $184), compared to HCA's -59.3% margin of safety (intrinsic $297 vs. $473).

Which stock has a wider economic moat, HCA Healthcare, Inc. or Morgan Stanley?▼

HCA scores 95/100 (Wide moat), while MS scores 80/100 (Wide moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Morgan Stanley in financial distress?▼

MS's Altman Z-Score of 0.3 places it in the Distress zone, signaling elevated bankruptcy risk. HCA scores 2.7 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, HCA Healthcare, Inc. or Morgan Stanley?▼

HCA earns 17.6% ROIC versus MS's 3.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, HCA Healthcare, Inc.'s or Morgan Stanley's?▼

HCA's dividend earns a safety score of 94/100 (Very Safe), compared to MS's 79/100 (Safe). HCA has raised its dividend for 3 consecutive years.